News

Oncaspar had previously been indicated for patients with acute lymphoblastic leukemia (ALL) who require L-asparaginase in their treatment, but developed hypersensitivity to the native forms. “We are pleased

Dosing was initiated in February 2006 and Critical Therapeutics expects to report preliminary results from this trial later this quarter. The company is developing zileuton IV initially for

In the trial the compound, atacicept (formerly referred to as TACI-Ig), demonstrated a favorable tolerability profile and indicated biological activity consistent with the mode of action. The primary

“With the availability of Keflex 750mg capsules, physicians and other healthcare professionals will be able to deliver a total daily dose of Keflex with fewer capsules per day,”

The grant was submitted in response to President George W Bush’s executive order encouraging innovation in manufacturing and provides funding of approximately $1.2 million over a two-year period.

Galapagos was awarded the grant through the Institute for the Promotion of Innovation by Science and Technology (IWT). As part of this program, Galapagos will collaborate with three

The randomized, double blind, placebo-controlled studies are intended to assess the efficacy and safety of pre-seasonal treatment with PreHistin on moderate to moderately severe seasonal ragweed allergy patients.

The collaboration, which will involve biological research aimed at understanding inflammatory signaling pathways, will initially last for a period of one and a half years. Shanghai Genomics, an

This effort includes the development of guidances to provide greater clarity and transparency in the disclosure of waivers of relationships that could present the appearance of conflicts of